Negative Pressure Wound Therapy Use: Recommendations and Insights From a Middle Eastern Panel of Experts
Year: 2025
Type: article
Abstract: The number of patients requiring wound care is increasing, placing a burden on healthcare institutions and clinicians. While negative pressure wound therapy (NPWT) use has become increasingly common, Middle East-specific wound care guidelines are limited. An in-person meeting was held in Dubai with 15 wound care experts to develop guidelines for NPWT and NPWT with instillation and dwell (NPWTi-d) use for the Middle East. A literature search was performed using PubMed, Science Direct and Cochrane Reviews. Prior to the meeting, panel members reviewed literature and existing guidelines on NPWT and/or NPWTi-d use. A wound management treatment algorithm was created. Patient and wound assessment at presentation and throughout the treatment plan was recommended. Primary closure was recommended for simple wounds, and NPWT use was suggested for complex wounds requiring wound bed preparation. NPWTi-d use was advised when wound cleansing is required, if the patient is unsuitable for surgical debridement, or if surgical debridement is delayed. When NPWTi-d is unavailable, panel members recommended NPWT. Panel members recommended NPWT for wound bed preparation and NPWTi-d when wound cleansing is needed. These recommendations provide general guidance for NPWT and NPWTi-d use and should be updated as more clinical evidence becomes available.
Source: International Wound Journal
DOI: 10.1111/iwj.70791
Institutions: Adan Hospital, King Faisal Specialist Hospital & Research Centre, King Abdullah Medical City, King Abdulaziz University, Riyadh Armed Forces Hospital, Sheikh Shakhbout Medical City, Cleveland Clinic Abu Dhabi, King Fahad Hospital Jeddah, Mediclinic City Hospital, King's College Hospital, University of Maryland, Baltimore, Milpark Hospital, The Royal Free Hospital
Language: English
Topic: Wound Healing and Treatments
Subfield: Rehabilitation
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,580
Funder: Solventum
OpenAlex ID: W4416734727
